Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2008
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1981858A2 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
10/22/2008EP1981838A2 Process for synthesis of glycomimicking cationic amphiphiles
10/22/2008EP1981501A2 Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008EP1287364B1 Diagnostics and therapeutics for macular degeneration-related disorders
10/22/2008EP0854729B2 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008CN101291926A 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
10/22/2008CN101291693A Novel use of il-1beta compounds
10/22/2008CN101291667A Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion
10/22/2008CN101289517A Process for abstracting momordica grosvenori polysaccharide
10/22/2008CN101289512A Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/22/2008CN101289510A Anti-CD40 monoclonal antibody
10/22/2008CN101289499A Cyclic peptide with -Ile-Sta-Sta-Pro- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289498A Cyclic peptide with -val-sta-leu- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289497A Cyclic peptide with -Ile-Sta-Sta-Tyr- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289477A N-phenylpropenoyl chitosan oligosaccharide and preparation thereof
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
10/22/2008CN101288750A Chinese medicine for modulating sub-health and its preparation method
10/22/2008CN101288735A Chinese medicinal composition for treating lupus erythermatosus and its preparation method
10/22/2008CN101288690A Anti-inflammation, anti-sensitivity, anti-shock medicament and preparation method thereof
10/22/2008CN101288665A Medicine containing alkannin compound as active component
10/22/2008CN101288664A Preparation method of magnetic nano microcapsule with nucleus/shell structure
10/22/2008CN101288643A Gel composition containing tacrolimu and its preparation method and medicinal application
10/22/2008CN101288475A Production method of flavor panax ginseng
10/22/2008CN101288470A Health-care beverage for strengthening immunity and preparation method thereof
10/22/2008CN100427504C TNF alpha high-affinity chimeric antibody and use thereof
10/22/2008CN100427126C Chinese herbal medicine enama for treating immunological eye diseases and its prepn process
10/22/2008CN100427105C Cell-repairing oral liquid
10/22/2008CN100427103C Activity combination of marine life and application
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439335 Synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439229 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine
10/21/2008US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
10/21/2008US7438905 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants
10/21/2008US7438903 Fine particle sizes; nanostructure; in mixture with oil, water carriers, excipients; oral diseases; cognition activators; hypotensive agents; immunology diseases; blood disorders
10/21/2008US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2333648C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
10/21/2008CA2247998C Fragments of cr1 and their use
10/21/2008CA2232294C Bioactive factors of aloe vera plants
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2174472C Arylalkylpyridazinones
10/19/2008CA2586226A1 Method for maintaining a surrogate body system for transplanting parts (of body) should illness require replacement
10/16/2008WO2008124838A1 Compounds that inhibit human dna ligases and methods of treating cancer
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008123800A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles
10/16/2008WO2008123796A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008122892A2 Probiotics for use in reducing eosinophilia and respiratory allergies
10/16/2008WO2008122174A1 A chinese medicine preparation for treating and preventing diabetes and its complication, improving immunity and process thereof
10/16/2008WO2008106116A3 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
10/16/2008WO2008099178A3 Binding members for ige molecules
10/16/2008WO2008011107A3 Antagonists of protease activated receptor-1 (par1)
10/16/2008US20080255225 Botanical Extract Composition
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants
10/16/2008US20080255121 Combination Drug for Treating Autoimmune Disease
10/16/2008US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
10/16/2008US20080255103 Antihistamine and anti-nausea pharmaceutical compositions for topical application
10/16/2008US20080255043 SP-D induces and increases apoptosis specifically in activated eosinophils derived from hypereosinophilic patients for the resolution of eosinophilia and eosinophil mediated pathogenic effects in eosinophil related diseases and disorders other than airway-hyperresponsiveness
10/16/2008US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254153 Water Dispersible Composition and Method for Preparing Same
10/16/2008US20080254143 synergistic mixture of plant extract of wolfberry (Lycium barbarum), and an extract of elderberry for increases the expression of IL-2 and TNF- alpha, production of cytokines; prevent viral infection from the common cold; oral administration; extract of blueberry, Echinacea root, Vitamin C, zinc acetate
10/16/2008US20080254137 Treatment of autoimmune disorders using detoxified cobratoxin
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/16/2008US20080254072 Method For Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens
10/16/2008US20080254071 Homeopathic composition for alleviating allergy symptoms
10/16/2008US20080254070 Bacterial secreted protein for use in generating vaccine for prevention of streptococcal infection; immunotherapy
10/16/2008US20080254069 Vaccines for immunization against helicobacter
10/16/2008US20080254068 Candida albicans CCM 8355; Candida glabrata CCM 8356; Candida krusei CCM 8357 and an immunomudulating Propionibacterium acnes strain; excipients, carriers
10/16/2008US20080254066 Emulsion comprising an aqueous phase, an oil phase, and a solvent and an immunogen
10/16/2008US20080254065 Influenza Virus Vaccines
10/16/2008US20080254064 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
10/16/2008US20080254062 Double mutation causes a non-functional Type III secretion system and etiher no CyaA protein or a non-functional CyaA protein; respiratory system disorders
10/16/2008US20080254060 Attenuated viruses comprising modified NS1 genes, having an impaired ability to antagonize the cellular interferon response; decreased in vivo replication, virulence and increased attenuation; live cancer vaccines
10/16/2008US20080254059 Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
10/16/2008US20080254058 Or surface-coupled proteins; a multivalent heterologous protein display vehicle; vaccines for infectious diseases, cancer, allergies, and autoimmune diseases
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 1172